18-2750446-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_015295.3(SMCHD1):c.4104C>T(p.Pro1368Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,611,098 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0024 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 22 hom. )
Consequence
SMCHD1
NM_015295.3 synonymous
NM_015295.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.29
Publications
3 publications found
Genes affected
SMCHD1 (HGNC:29090): (structural maintenance of chromosomes flexible hinge domain containing 1) This gene encodes a protein which contains a hinge region domain found in members of the SMC (structural maintenance of chromosomes) protein family. [provided by RefSeq, Dec 2011]
SMCHD1 Gene-Disease associations (from GenCC):
- arhinia, choanal atresia, and microphthalmiaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics, ClinGen, Illumina
- facioscapulohumeral muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 18-2750446-C-T is Benign according to our data. Variant chr18-2750446-C-T is described in ClinVar as Benign. ClinVar VariationId is 260647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.29 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00237 (360/152084) while in subpopulation EAS AF = 0.033 (171/5186). AF 95% confidence interval is 0.0289. There are 5 homozygotes in GnomAd4. There are 165 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 360 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMCHD1 | NM_015295.3 | c.4104C>T | p.Pro1368Pro | synonymous_variant | Exon 32 of 48 | ENST00000320876.11 | NP_056110.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00236 AC: 359AN: 151966Hom.: 5 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
359
AN:
151966
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00474 AC: 1160AN: 244746 AF XY: 0.00373 show subpopulations
GnomAD2 exomes
AF:
AC:
1160
AN:
244746
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00154 AC: 2243AN: 1459014Hom.: 22 Cov.: 31 AF XY: 0.00142 AC XY: 1031AN XY: 725652 show subpopulations
GnomAD4 exome
AF:
AC:
2243
AN:
1459014
Hom.:
Cov.:
31
AF XY:
AC XY:
1031
AN XY:
725652
show subpopulations
African (AFR)
AF:
AC:
18
AN:
33428
American (AMR)
AF:
AC:
650
AN:
44292
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
26000
East Asian (EAS)
AF:
AC:
1139
AN:
39580
South Asian (SAS)
AF:
AC:
154
AN:
85928
European-Finnish (FIN)
AF:
AC:
2
AN:
53304
Middle Eastern (MID)
AF:
AC:
4
AN:
5750
European-Non Finnish (NFE)
AF:
AC:
79
AN:
1110458
Other (OTH)
AF:
AC:
193
AN:
60274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.429
Heterozygous variant carriers
0
102
205
307
410
512
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00237 AC: 360AN: 152084Hom.: 5 Cov.: 32 AF XY: 0.00222 AC XY: 165AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
360
AN:
152084
Hom.:
Cov.:
32
AF XY:
AC XY:
165
AN XY:
74326
show subpopulations
African (AFR)
AF:
AC:
46
AN:
41502
American (AMR)
AF:
AC:
107
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
171
AN:
5186
South Asian (SAS)
AF:
AC:
19
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10570
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6
AN:
67958
Other (OTH)
AF:
AC:
11
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
85
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Jun 02, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 07, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Facioscapulohumeral muscular dystrophy 2 Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.